Neogen (NEOG) Stock Forecast & Price Target

Neogen is positioned for a constructive turnaround because the company has delivered several consecutive quarters of improving performance, with Food Safety growth accelerating, adjusted EBITDA margins rising, positive free cash flow, and restored product availability under a more disciplined commercial strategy. The outlook is further supported by management’s expectation that Food Safety can grow around nominal GDP near ~4% in the near to mid-term, while Animal Safety stabilizes, and by the chance for combined long-term growth to reach ~HSD% as adjacencies expand. Incremental upside also comes from Petrifilm, where validation of equipment is complete, the 17 SKUs are progressing, the manufacturing transition is targeted for November 2026, and the company generated $26.2 million of free cash flow in the fourth quarter with leverage expected to move below 3x by the end of calendar 2026, subject to closing.

Neogen is facing a negative fundamental setup because it must absorb the operational complexity of onboarding Petrifilm manufacturing while also finalizing the integration of 3M assets and personnel, both of which can slow execution, disrupt production, and lift expenses. The larger debt load used to finance the 3M transaction has increased interest expense and reduced liquidity, leaving the company more exposed if top-line growth does not keep pace with the enlarged organization. In addition, its exposure to cyclical food and animal safety markets, inflation, supply chain disruptions, and intense competition makes sustained margin and revenue improvement harder to achieve.